-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Kairos Pharma, LTD. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2023 to Q3 2025.
- Kairos Pharma, LTD. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$1.4M, a 33.5% decline year-over-year.
- Kairos Pharma, LTD. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$5.06M.
- Kairos Pharma, LTD. annual Net Income (Loss) Attributable to Parent for 2024 was -$2.6M, a 43.7% decline from 2023.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)